Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage.

Morillas P, de Andrade H, Castillo J, Quiles J, Bertomeu-González V, Cordero A, Tarazón E, Roselló E, Portolés M, Rivera M, Bertomeu-Martínez V.

Rev Esp Cardiol (Engl Ed). 2012 Sep;65(9):819-25. Epub 2012 Jul 7. English, Spanish.

PMID:
22771083
2.

Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage.

Morillas P, Quiles J, de Andrade H, Castillo J, Tarazón E, Roselló E, Portolés M, Rivera M, Bertomeu-Martínez V.

J Hypertens. 2013 Aug;31(8):1611-7. doi: 10.1097/HJH.0b013e3283614c1c.

PMID:
23615327
3.

Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension.

Takiuchi S, Kamide K, Miwa Y, Tomiyama M, Yoshii M, Matayoshi T, Horio T, Kawano Y.

J Hum Hypertens. 2004 Jan;18(1):17-23.

PMID:
14688806
4.

Carotid resistive index in treated hypertensive patients: relationship with target organ damage.

Morillas P, Quiles J, Mateo I, Bertomeu-González V, Castillo J, de Andrade H, Roldán J, Miralles B, Masiá MD, Carrillo P, Bertomeu-Martínez V.

Blood Press. 2012 Dec;21(6):360-6. doi: 10.3109/08037051.2012.694181. Epub 2012 Jul 3.

PMID:
22747334
5.
6.

Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension.

Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, Emdin M, Flacco M, Schillaci G, DE Caterina R.

Hypertens Res. 2008 Dec;31(12):2137-46. doi: 10.1291/hypres.31.2137.

PMID:
19139603
7.

Microalbuminuria is an early marker of target organ damage in essential hypertension.

Pontremoli R, Nicolella C, Viazzi F, Ravera M, Sofia A, Berruti V, Bezante GP, Del Sette M, Martinoli C, Sacchi G, Deferrari G.

Am J Hypertens. 1998 Apr;11(4 Pt 1):430-8.

PMID:
9607381
8.

Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients.

Blázquez-Medela AM, García-Ortiz L, Gómez-Marcos MA, Recio-Rodríguez JI, Sánchez-Rodríguez A, López-Novoa JM, Martínez-Salgado C.

BMC Med. 2010 Dec 20;8:86. doi: 10.1186/1741-7015-8-86.

9.
10.

Increased plasma plasminogen activator inhibitor-1 levels: a possible marker of hypertensive target organ damage.

Diamantopoulos EJ, Andreadis EA, Vassilopoulos CV, Theodorides TG, Giannakopoulos NS, Chatzis NA, Christopoulou-Kokkinou VD.

Clin Exp Hypertens. 2003 Jan;25(1):1-9.

PMID:
12597520
11.

Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure.

Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, Lonati L, Magrini F, Zanchetti A.

J Hypertens. 2004 Feb;22(2):273-80.

PMID:
15076184
12.

Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.

Navarro-González JF, Mora C, Muros M, Jarque A, Herrera H, García J.

J Hypertens. 2008 Nov;26(11):2168-75. doi: 10.1097/HJH.0b013e32830e2545.

PMID:
18854757
13.

Masked hypertension and target organ damage in treated hypertensive patients.

Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S, Yoshihara F, Nakahama H, Inenaga T, Kawano Y.

Am J Hypertens. 2006 Sep;19(9):880-6.

PMID:
16942927
14.

Metabolic syndrome and target organ damage in untreated essential hypertensives.

Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A.

J Hypertens. 2004 Oct;22(10):1991-8.

PMID:
15361772
15.

Elevating circulation chemerin level is associated with endothelial dysfunction and early atherosclerotic changes in essential hypertensive patients.

Gu P, Cheng M, Hui X, Lu B, Jiang W, Shi Z.

J Hypertens. 2015 Aug;33(8):1624-32. doi: 10.1097/HJH.0000000000000588.

PMID:
26136068
16.

[Cardiac and vascular morphology in patients with "white-coat hypertension": echocardiographic and ultrasonographic study].

Cuspidi C, Marabini M, Lonati L, Sampieri L, Pontiggia G, Pelizzoli S, Leonetti G.

G Ital Cardiol. 1995 Dec;25(12):1581-7. Italian.

PMID:
8707006
17.

Effect of blood pressure and physical activity on carotid artery intima-media thickness in stage 1 hypertensives and controls.

Casiglia E, Palatini P, Da Ros S, Pagliara V, Puato M, Dorigatti F, Pauletto P.

Am J Hypertens. 2000 Dec;13(12):1256-62.

PMID:
11130768
18.

Left atrial diameter, flow-mediated dilation of brachial artery and target organ damage in Chinese patients with hypertension.

Xu JZ, Wu SY, Yan YQ, Xie YS, Ren YR, Yin ZF, Shi CZ, Wang CQ.

J Hum Hypertens. 2012 Jan;26(1):41-7. doi: 10.1038/jhh.2010.129. Epub 2011 Feb 3.

PMID:
21289644
19.

Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives.

Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, Aronne L, Credendino M, Siniscalchi C, Calabrò P, Cotrufo M, Calabrò R.

Eur J Echocardiogr. 2009 Jun;10(4):549-55. doi: 10.1093/ejechocard/jep002. Epub 2009 Feb 10.

PMID:
19211568
20.

Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients.

Cuspidi C, Meani S, Lonati L, Fusi V, Valerio C, Sala C, Magnaghi G, Maisaidi M, Zanchetti A.

J Hypertens. 2006 Apr;24(4):647-53.

PMID:
16531792

Supplemental Content

Support Center